TIAA CREF Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.24M | Buy |
101,665
+3,988
| +4% | +$48.6K | ﹤0.01% | 2221 |
|
|
2018
Q4 | $1.11M | Buy |
97,677
+11,715
| +14% | +$133K | ﹤0.01% | 2243 |
|
|
2018
Q3 | $1.87M | Sell |
85,962
-46,538
| -35% | -$1.01M | ﹤0.01% | 2152 |
|
|
2018
Q2 | $2.34M | Sell |
132,500
-87,173
| -40% | -$1.54M | ﹤0.01% | 2085 |
|
|
2018
Q1 | $4.62M | Buy |
219,673
+45,053
| +26% | +$948K | ﹤0.01% | 1598 |
|
|
2017
Q4 | $2.53M | Buy |
174,620
+66,464
| +61% | +$962K | ﹤0.01% | 2002 |
|
|
2017
Q3 | $1.71M | Sell |
108,156
-2,769
| -2% | -$43.7K | ﹤0.01% | 2250 |
|
|
2017
Q2 | $1.38M | Sell |
110,925
-29,155
| -21% | -$362K | ﹤0.01% | 2390 |
|
|
2017
Q1 | $2.28M | Sell |
140,080
-2,179
| -2% | -$35.4K | ﹤0.01% | 2056 |
|
|
2016
Q4 | $2.15M | Sell |
142,259
-6,672
| -4% | -$101K | ﹤0.01% | 2151 |
|
|
2016
Q3 | $2.27K | Sell |
148,931
-2,335
| -2% | -$36 | ﹤0.01% | 2099 |
|
|
2016
Q2 | $5.87M | Buy |
151,266
+25,751
| +21% | +$1,000K | ﹤0.01% | 1419 |
|
|
2016
Q1 | $3.49M | Buy |
125,515
+15,245
| +14% | +$424K | ﹤0.01% | 1746 |
|
|
2015
Q4 | $5.93M | Buy |
110,270
+22,284
| +25% | +$1.2M | ﹤0.01% | 1442 |
|
|
2015
Q3 | $3.52M | Sell |
87,986
-6,528
| -7% | -$261K | ﹤0.01% | 1783 |
|
|
2015
Q2 | $3.02M | Buy |
94,514
+30,025
| +47% | +$959K | ﹤0.01% | 2034 |
|
|
2015
Q1 | $1.54M | Sell |
64,489
-2,033
| -3% | -$48.5K | ﹤0.01% | 2384 |
|
|
2014
Q4 | $1.17M | Buy |
66,522
+1,797
| +3% | +$31.7K | ﹤0.01% | 2566 |
|
|
2014
Q3 | $887K | Hold |
64,725
| – | – | ﹤0.01% | 2704 |
|
|
2014
Q2 | $1.09M | Buy |
+64,725
| New | +$1.09M | ﹤0.01% | 2676 |
|